Abstract
Purpose To determine the ultrastructural localisation of glycosaminoglycans (GAGs) in the extraocular muscles (EOMs) of patients with thyroid-associated ophthalmopathy (TAO) and to see whether the quantity and type of GAGs present in blood and urine are markers of the disease.
Methods Biopsies of affected EOMs were taken and studied by transmission electron microscopy (TEM). These were either fixed conventionally for TEM, or in 0.5% tannic acid and others for immunogold staining. Serum hyaluronan (HA) was measured using a radioimmunoassay in patients with TAO as well as control subjects, and urinary GAG levels assessed by photometric quantitation of hexuronic acid after reaction with carbazole. The excretion pattern of the urinary GAGs was determined by discontinuous electrophoresis.
Results TEM showed that there is a marked ficpansion of the endomysial space in TAO EOM biopsies as compared with non-TAO strabismus specimens. This is caused by an increased number of collagen fibres. interspersed with a granular amorphous material surrounding striated collagen fibres shown to be hyaluronan by immunogold ftaining. In contrast, serum hyaluronan concentrations were similar in TAO and control patients, although there was a statistically significant difference in the ttrinary GAG excretion between the two groups of patients examined. By discontinuous electrophoresis, chondroitin ivlphate and heparan sulphate were present in both patients and controls.
Conclusion GAGs and in particularly HA are present at the EOM level in patients with jecently inactive TAO. However, serum levels of HA and urinary GAGs are not sensitive indicators for their presence within the EOMs.
Similar content being viewed by others
Article PDF
References
Fells P . Thyroid-associated eye disease: clinical management. Lancet 1991;338:29–32.
Jacobson DH, Gorman CA . Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment. Endocr Rev 1984;5:200–20.
Wall JR, Salvi M, Bernard NF, Boucher A, Haegert D . Thyroid-associated ophthalmopathy: a model for the association of organ-specific autoimmune disorders. Immunol Today 1991;12:150–3.
Weetman AP . Thyroid-associated eye disease: pathophysiology. Lancet 1991;338:25–8.
Bahn RS, Heufelder AE . Pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993;329:1468–75.
Perros P, Kendall-Taylor P . Thyroid-associated ophthalmopathy: pathogenesis and clinical management. Baillieres Clin Endocrinol Metab 1995;9:115–35.
Sridama V, de Groot LJ . Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 1989;87:70–3.
Hufnagel TJ, Hickey WF, Cobbs NH, Jakobiec FA, Iwamoto T, Eagle RC . Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 1984;91:1411–9.
Weetman AP, Cohen S, Gatter KC, Fells P, Shine B . Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989;75:222–7.
Hiromatsu Y, Tanaka K, Ishisaka N, et at. Human histocompatibility leukocyte antigen-DR and heat shock protein-70 expression in eye muscle tissue in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 1995;80:685–91.
Kroll AJ, Kuwabara T . Dysthyroid ocular myopathy: anatomy, histology, and electron microscopy. Arch Ophthalmol 1966;76:244–57.
Riley FC . Orbital pathology in Graves' disease. Mayo Clin Proc 1972;47:975–9.
Tallstedt L, Norberg R . Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophthalmol Vis Sci 1988;29:175–84.
Campbell RJ . Immunology of Graves' ophthalmopathy: retrobulbar histology and histochemistry. Acta Endocrinol (Copenh) 1989;121 (Suppl 2):9–16.
Scott JE . Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues. FASEB J 1992;6:2639–45.
Kahaly G, Schuler M, Sewell AC, Bernhard G, Beyer J, Krause U . Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol 1990;33:35–44.
Kahaly G, Hansen C, Beyer J, Winand R . Plasma glycosaminoglycans in endocrine ophthalmopathy. J Endocrinol Invest 1994;17:45–50.
Imai Y, Odajima R, Shimizu T, Shishiba Y . Serum hyaluronan concentration determined by radiometric assay in patients with pretibial myxedema and Graves' ophthalmopathy. Endocrinol Jpn 1990;37:749–52.
Robertson D, Monaghan P, Clarke C, Atherton AJ . An appraisal of low-temperature embedding by progressive lowering of temperature into Lowicryl HM20 for immunocytochemical studies. J Microsc 1992;168:85–100.
Engstrom-Laurent A, Laurent UBG, Lilja K, Laurent TC . Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985;45:497–504.
Di Ferrante N . The measurement of urinary mucopolysaccharides. Anal Biochem 1967;21:98–106.
Pennock CA, Charles RG, Stansbie D . Glycosaminoglycan fractions in normal human urine. Ann Clin Biochem 1975;12:207–11.
Bitter T, Muir HM . A modified uronic acid carbazole reaction. Anal Biochem 1962;4:330–4.
Hopwood JJ, Harrison JR . High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses. Anal Biochem 1982;119:120–7.
Fells P, Kousoulides L, Pappa A, Munro P, Lawson J . Extraocular muscle problems in thyroid eye disease. Eye 1994;8:497–505.
Imai Y, Odajima R, Inoue Y, Shishiba Y . Effect of growth factors on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts of Graves' ophthalmopathy in culture. Acta Endocrinol (Copenh) 1992;126:541–52.
Engstrom-Laurent A, Hallgren R . Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985;44:83–8.
Levesque H, Delpech B, Le Loet X, Deshayes P . Serum hyaluronate in rheumatoid arthritis: study of affino-immunoenzymatic assay. Br J Rheumatol 1988;27:445–9.
Winand RJ . Increased urinary excretion of acidic mucopolysaccharides in exophthalmos. J Clin Invest 1968;47:2563–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pappa, A., Jackson, P., Stone, J. et al. An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy. Eye 12, 237–244 (1998). https://doi.org/10.1038/eye.1998.57
Issue Date:
DOI: https://doi.org/10.1038/eye.1998.57
Keywords
This article is cited by
-
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves’ orbitopathy
Graefe's Archive for Clinical and Experimental Ophthalmology (2010)